Table 2.
A. Team composition | ||
---|---|---|
Component | Required | Recommended (either at primary institution or through referral) |
Program director: The primary clinical focus is pediatric PH. May have protected PH research time |
⊗ | |
PH team subspecialties: Multidisciplinary team for direct PH care | Pediatric cardiology and/or pediatric pulmonology |
Neonatology pediatric Intensive care Pediatric Pulmonology/cardiology |
Consulting services: Collaboration between PH team and consultant services |
Genetics Palliative care Rheumatology Gastroenterology Physical Medicine and rehabilitation Cardiac anesthesia Interventional cardiology Cardiac surgery |
Surgeons skilled in thromboendarterectomy (referral basis) Lung transplant specialists Developmentalist Palliative care Pediatric surgery |
Program coordinator (recommended RN or APP): Performs coordination of care between patient, specialty pharmacies, and insurance companies; first line of team contact for patient/caregiver |
⊗ | |
Nurse practitioner: Provides medical and research support through inpatient and outpatient care including transition, communication with family and prostacyclin management |
⊗ | |
Ancillary services: Diverse team to work with medical team for interdisciplinary care delivery of comprehensive services and assessment |
Social worker Pharmacist dietician Child life Administrative support |
Pain management Genetics counselor/genetics |
B. Treatments, services, and facilities offered for patient care | ||
---|---|---|
Pediatric interventional cardiology/pediatric cardiothoracic surgery |
Acute vasodilator testing Atrial septostomy Ductus arteriosus stent |
Reverse Potts shunt Lung transplantation |
Continuous patient care coverage: Daily service and physician call schedule for PH patients | ⊗ | |
Comprehensive offering of vasodilator therapies: Expertise with all available pulmonary vasodilator treatments (oral, inhaled, subcutaneous, intravenous) |
⊗ | |
Patient, caregiver, and staff education: Education on prostacyclin therapy inpatient and at home |
⊗ | |
Treatment expertise: All WSPH/Panama classification groups of PH |
Provide comprehensive care or consultation on neonatal/infant Group 3 patients | CTEPH program |
Transition pathway: Identified partner for continuing adult care |
⊗ | |
Referral destination: Center for regional and affiliate partners, able to provide care for Medicaid patients |
⊗ | |
Full ancillary testing: Echocardiogram, catheterization, CT/MRI, V/Q, CPET, 6MWT, PFT | ⊗ | |
Institutional support: Recognized role of PH team within institution, support for expansion |
⊗ |
C. Scholarly activity: research and education | ||
---|---|---|
Active participation in research: Industry‐sponsored, PI‐initiated, registries | ⊗ | |
Research support | Research coordinator | Statistician |
Education of learners: Students, residents, fellows, colleagues |
⊗ | |
Hospital staff education | ⊗ | |
Conference participation: Regional (as applicable), local and national conferences |
⊗ | |
Commitment to quality improvement: Regular projects for program self‐assessment and growth |
⊗ |